[Drug therapy in the secondary prevention of atherosclerosis].
Kettunen
Raimo
R
Päijät-Hämeen keskussairaala, sisätaudit Keskussairaalankatu 7 15850 Lahti. raimo.kettunen@phks.fi
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors